Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

RYTMRYTM
Showing 8 of 26 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in RHYTHM PHARMACEUTICALS INC

PRICE T ROWE ASSOCIATES INC /MD/ holds 2.6M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $284.9M as of 2026-Q2. The position was increased (+55.1% shares). RYTM represents 0.0% of PRICE T ROWE ASSOCIATES INC /MD/'s portfolio.

Current Value

$284.9M

Current Shares

2.6M

Total Value Change

+$256.1M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+55.1%
$284.9M0.0%$111.03
44
2026-Q1
Increased
1.7M
+6.0%
$143.9M0.0%$86.97
32
2025-Q4
Increased
1.6M
+11.5%
$167.1M0.0%$107.04
34
2025-Q3
Increased
1.4M
+4.4%
$141.4M0.0%$100.99
32
2025-Q2
Increased
1.3M
+11.9%
$84.8M0.0%$63.19
33
2025-Q1
Increased
1.2M
+75.0%
$63.5M0.0%$52.97
45
2024-Q4
Increased
685,152
+24.4%
$38.4M0.0%$55.98
35
2024-Q3
Increased
550,530
+4.7%
$28.8M0.0%$52.39
30

Other major holders of RYTM: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used